Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Active, not recruiting · NCT02921022 · Registry updated 2025-11-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma | Digestive System Diseases, Digestive System Neoplasms, Embolism and Thrombosis, Neoplasms by Site, Thromboembolism, cardiovascular disorder, endocrine system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, vascular disorder | Active, not recruiting | Not applicable | 2025-11-26 | NCT02921022 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Halozyme Therapeutics | 3 |
| Memorial Sloan Kettering Cancer Center | 753 |
| Miami Cancer Institute | 4 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hartford Healthcare Cancer Institute @ Hartford Hospital | Hartford | United States | 7 |
| Lehigh Valley Health Network | Allentown | United States | 35 |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge | United States | 8 |
| Memorial Sloan Kettering Bergen | Montvale | United States | 193 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Memorial Sloan Kettering Commack | Commack | United States | 189 |
| Memorial Sloan Kettering Monmouth | Middletown | United States | 206 |
| Memorial Sloan Kettering Nassau | Uniondale | United States | 193 |
| Memorial Sloan Kettering Westchester | Harrison | United States | 204 |
| Miami Cancer Institute | Miami | United States | 3 |